An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

How Do Animals Perceive Music?

‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely

Rizatriptan vs. Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial

Recent Posts

ASLP-IC Readies for Rollout: Here’s What You Need to Know

The Audiology and Speech-Language Pathology Interstate Compact (ASLP-IC) continues to move toward full implementation, expanding opportunities for audiologists and speech-language pathologists to practice across state…

Read More

How Do Animals Perceive Music?

Music can be defined as vocal, instrumental, or mechanical sounds, with rhythm, melody or harmony, and often, an expression of human emotion. Music can transcend…

Read More

‘Eye’ on Health: AI Detects Dizziness and Balance Disorders Remotely

Interesting research led by audiologist Ali Danesh, PhD, at Florida Atlantic University (FAU) helped develop a novel, proof-of-concept tool to help identify nystagmus using a…

Read More